Graham Dawn

Director at ACELYRIN, Inc. · on record since May 11, 2023
Director at MEDIVATION, INC. · on record since Apr 30, 2013
Director at Xenon Pharmaceuticals Inc. · on record since Jun 3, 2026
Director at PTC THERAPEUTICS, INC. · on record since Jun 13, 2016
Director at ENDOCYTE INC · on record since May 4, 2018
Director at Global Blood Therapeutics, Inc. · on record since Dec 21, 2018
Director at Avalanche Biotechnologies, Inc. · on record since Dec 11, 2020

Insider trading activity of Graham Dawn

Transactions on record: 114; since Apr 23, 2013

Open-market buys: 5; $974.2K

Open-market sells: 13; $2.3M

Companies traded: 7; last filing Jun 3, 2026

Figures computed from official regulatory filings — methodology.

Companies where Graham Dawn has traded

Xenon Pharmaceuticals Inc.18 tx · $1.2M · Jun 3, 2026
Avalanche Biotechnologies, Inc.15 tx · $225.9K · Dec 10, 2025
ACELYRIN, Inc.11 tx · $270K · May 23, 2025
Global Blood Therapeutics, Inc.26 tx · $273.4K · Oct 6, 2022
PTC THERAPEUTICS, INC.16 tx · $438.7K · Jun 10, 2022
ENDOCYTE INC6 tx · $723.2K · Dec 21, 2018
MEDIVATION, INC.22 tx · $910.9K · Sep 30, 2016

Track record of Graham Dawn

Statistical track record

Free

Open-market buys: 5

Last buy: May 9, 2023

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Graham Dawn

Co-insiders of Graham Dawn

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Xenon Pharmaceuticals Inc.	Jun 3, 2026	AwardD	1,593	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	ExerciseD	-2,645	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	AwardD	10,507	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	Other	-1,416	53.41 USD	$75.6K	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	Exercise	2,645	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,500	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	Other	-5,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-10,520	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-10,450	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Jun 20, 2025	AwardD	10,450	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 6, 2025	AwardD	2,645	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 6, 2025	AwardD	17,012	0.00 USD	$0	SEC
ACELYRIN, Inc.	May 23, 2025	OtherD	-155,450	—	—	SEC
ACELYRIN, Inc.	May 23, 2025	OtherD	-23,243	—	—	SEC
ACELYRIN, Inc.	May 23, 2025	OtherD	-92,158	—	—	SEC
ACELYRIN, Inc.	May 23, 2025	Other	-15,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Jun 20, 2024	AwardD	10,520	0.00 USD	$0	SEC
ACELYRIN, Inc.	Jun 11, 2024	AwardD	92,158	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 5, 2024	AwardD	15,542	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Aug 24, 2023	Sell	-25,000	38.70 USD	$967.5K	SEC
Avalanche Biotechnologies, Inc.	Jun 13, 2023	AwardD	40,000	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 2, 2023	AwardD	18,475	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Xenon Pharmaceuticals Inc.	Jun 3, 2026	AwardD	1,593	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	ExerciseD	-2,645	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	AwardD	10,507	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	Other	-1,416	53.41 USD	$75.6K	SEC
Xenon Pharmaceuticals Inc.	Jun 3, 2026	Exercise	2,645	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,500	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	Other	-5,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-10,520	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-10,450	—	—	SEC
Avalanche Biotechnologies, Inc.	Dec 10, 2025	OtherD	-4,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Jun 20, 2025	AwardD	10,450	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 6, 2025	AwardD	2,645	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 6, 2025	AwardD	17,012	0.00 USD	$0	SEC
ACELYRIN, Inc.	May 23, 2025	OtherD	-155,450	—	—	SEC
ACELYRIN, Inc.	May 23, 2025	OtherD	-23,243	—	—	SEC
ACELYRIN, Inc.	May 23, 2025	OtherD	-92,158	—	—	SEC
ACELYRIN, Inc.	May 23, 2025	Other	-15,000	—	—	SEC
Avalanche Biotechnologies, Inc.	Jun 20, 2024	AwardD	10,520	0.00 USD	$0	SEC
ACELYRIN, Inc.	Jun 11, 2024	AwardD	92,158	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 5, 2024	AwardD	15,542	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Aug 24, 2023	Sell	-25,000	38.70 USD	$967.5K	SEC
Avalanche Biotechnologies, Inc.	Jun 13, 2023	AwardD	40,000	0.00 USD	$0	SEC
Xenon Pharmaceuticals Inc.	Jun 2, 2023	AwardD	18,475	0.00 USD	$0	SEC